Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 25 of 715 entries
View as:

To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00415883 Org: User:
Start: 07/31/06 End: - Due: -

A Study to Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT06395909 Org: User:
Start: 04/23/23 End: 08/31/23 Due: 08/31/24

Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00353912 Org: User:
Start: 06/30/06 End: 04/30/07 Due: 04/30/08

Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00367094 Org: User:
Start: 07/31/06 End: - Due: -

Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00413920 Org: User:
Start: 04/30/07 End: - Due: -

Long-term Efficacy, Safety and Tolerability of ACZ885 in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00554606 Org: User:
Start: 10/11/07 End: 08/13/09 Due: 08/13/10

Therapeutic Management and Use of Resources and Costs of Spinal Muscular Atrophy in Spain

Phase: N/A Priority: Normal
NCT ID: NCT06632730 Org: User:
Start: 07/05/23 End: 11/20/23 Due: 11/20/24

Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function

Phase: N/A Priority: Normal
NCT ID: NCT00416702 Org: User:
Start: 11/30/06 End: 03/31/08 Due: 03/31/09

Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions

Phase: N/A Priority: Normal
NCT ID: NCT00029224 Org: User:
Start: 10/31/01 End: 11/30/02 Due: 11/30/03

Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension.

Phase: N/A Priority: Normal
NCT ID: NCT00343551 Org: User:
Start: 05/31/06 End: - Due: -

6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00170872 Org: User:
Start: 11/30/04 End: - Due: -

Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006269 Org: User:
Start: 12/31/99 End: - Due: -

Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00354016 Org: User:
Start: 07/31/06 End: - Due: -

Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00240955 Org: User:
Start: 03/31/04 End: 05/31/06 Due: 05/31/07

Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00289978 Org: User:
Start: 01/31/06 End: 07/31/09 Due: 07/31/10

A Compassionate Access Protocol to Assess the Safety of XolairTM (Omalizumab) in Patients (≥ 6 Years Old) With Severe Allergic Asthma Who Remain Symptomatic Despite Optimal Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00639691 Org: User:
Start: 01/31/05 End: 12/31/11 Due: 12/31/12

Hypertension and Cardiovascular Risk Factors

Phase: N/A Priority: Normal
NCT ID: NCT00171782 Org: User:
Start: 02/29/04 End: 12/31/04 Due: 12/31/05

Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01438996 Org: User:
Start: 10/31/11 End: 12/31/11 Due: 12/31/12

Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00927394 Org: User:
Start: 05/31/09 End: 10/31/11 Due: 10/31/12

Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00396604 Org: User:
Start: 10/31/06 End: 01/31/07 Due: 01/31/08

STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00006052 Org: User:
Start: 06/30/00 End: - Due: -

Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT00646542 Org: User:
Start: 03/31/05 End: - Due: -

"ALOFT - Aliskiren Observation of Heart Failure Treatment": Efficacy and Safety of Aliskiren Added on Top of Standard Therapy in Adults (≥ 18 Years) With Stable Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00219011 Org: User:
Start: 05/31/05 End: 02/28/07 Due: 02/28/08

Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00396656 Org: User:
Start: 12/31/05 End: 12/31/07 Due: 12/31/08

Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00128232 Org: User:
Start: 12/31/02 End: - Due: -